Form D · Other

Ten Bay Bio, Inc.

Milwaukee, WI · CIK 0002032513

Offering snapshot reported May 13, 2025 · SEC filing

Reported sold
$11.5M
Offering amount: $11.5M
Investors reported
6
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 23, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$5.77M$11.5MAug 6, 2024: $3,899,999.00Aug 6, 2024May 13, 2025: $11,549,996.00May 13, 2025

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$3,899,999 → $11,549,996
  • Reported investors4 → 6

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 13, 2025Amendment$11,549,996$7,649,997vs Aug 6, 20246SEC filing
Aug 6, 2024Initial$3,899,999No comparison4SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-520719

Source: Form D, filed May 13, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Casey Cunningham Director
Andrew Kadlec Director, Executive
Omar Khalil Director
Tim Mayleben Director
Paul Weiss Director

Issuer details

Industry: Other (See others in industry)

Address:
4816 W. Wisconsin Avenue
Milwaukee, WI, 53208